Frontiers DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic
Molecular basis for kinin selectivity and activation of the human
COVID-19 Transmission, Current Treatment, and Future Therapeutic
Kallikrein-kinin blockade in patients with COVID-19 to prevent
Mechanisms of COVID-19 pathogenesis in diabetes
The 'Bradykinin Hypothesis' - How COVID-19 Enters The Body
The mechanism underlying extrapulmonary complications of the
Bradykinin hypothesis' may explain how COVID-19 attacks the human
Bradykinin-target therapies in SARS-CoV-2 infection: current
SARS-CoV-2 and the spike protein in endotheliopathy: Trends in
COVID-19 Storms: Bradykinin In, Cytokine Out?
Current and novel biomarkers of thrombotic risk in COVID-19: a
Biomarkers found in COVID-19 patients - Support bradykinin
Frontiers Why Is COVID-19 More Severe in Patients With Diabetes
FAPESP selects first projects in call to combat COVID-19